Your browser doesn't support javascript.
loading
Trastuzumab ± Capecitabine Maintenance After the First-Line Treatment of HER2-Positive Advanced Gastric Cancer: Retrospective Observational Real-Life Data of Turkish Oncology Group.
Gürbüz, Mustafa; Akkus, Erman; Sakin, Abdullah; Urvay, Semiha; Demiray, Atike Gökçen; Sahin, Süleyman; Sakalar, Teoman; Erol, Cihan; Sendur, Mehmet Ali Nahit; Sahin, Ahmet Bilgehan; Çubukçu, Erdem; Güven, Deniz Can; Kiliçkap, Saadettin; Ergün, Yakup; Uncu, Dogan; Turhal, Nazim Serdar; Üskent, Necdet; Çinkir, Havva Yesil; Demir, Atakan; Acar, Ramazan; Karadurmus, Nuri; Türker, Sema; Altinbas, Mustafa; Karaoglan, Mert; Senler, Filiz Çay.
Afiliação
  • Gürbüz M; Faculty of Medicine, Department of Medical Oncology, Ankara University, Ankara, Turkey. mgurbuz@ankara.edu.tr.
  • Akkus E; Faculty of Medicine, Department of Internal Medicine, Ankara University, Ankara, Turkey.
  • Sakin A; Faculty of Medicine, Department of Medical Oncology, Van Yüzüncü Yil University, Van, Turkey.
  • Urvay S; Department of Medical Oncology, Kayseri Acibadem Hospital, Kayseri, Turkey.
  • Demiray AG; Faculty of Medicine, Department of Medical Oncology, Pamukkale University, Denizli, Turkey.
  • Sahin S; Department of Medical Oncology, University of Health Sciences, Van Training and Research Hospital, Van, Turkey.
  • Sakalar T; Department of Medical Oncology, Necip Fazil City Hospital, Kahramanmaras, Turkey.
  • Erol C; Faculty of Medicine, Department of Medical Oncology, Yildirim Beyazit University, Ankara, Turkey.
  • Sendur MAN; Faculty of Medicine, Department of Medical Oncology, Yildirim Beyazit University, Ankara, Turkey.
  • Sahin AB; Faculty of Medicine, Department of Medical Oncology, Uludag University, Bursa, Turkey.
  • Çubukçu E; Faculty of Medicine, Department of Medical Oncology, Uludag University, Bursa, Turkey.
  • Güven DC; Faculty of Medicine, Department of Medical Oncology, Hacettepe University, Ankara, Turkey.
  • Kiliçkap S; Faculty of Medicine, Department of Medical Oncology, Hacettepe University, Ankara, Turkey.
  • Ergün Y; Department of Medical Oncology, Ankara City Hospital, Ankara, Turkey.
  • Uncu D; Department of Medical Oncology, Ankara City Hospital, Ankara, Turkey.
  • Turhal NS; Anadolu Medical Center, Department of Medical Oncology, Kocaeli, Turkey.
  • Üskent N; Anadolu Medical Center, Department of Medical Oncology, Kocaeli, Turkey.
  • Çinkir HY; Faculty of Medicine, Department of Medical Oncology, Gaziantep University, Gaziantep, Turkey.
  • Demir A; Department of Medical Oncology, Maslak Acibadem Hospital, Istanbul, Turkey.
  • Acar R; Department of Medical Oncology, University of Health Sciences, Gülhane Training and Research Hospital, Ankara, Turkey.
  • Karadurmus N; Department of Medical Oncology, University of Health Sciences, Gülhane Training and Research Hospital, Ankara, Turkey.
  • Türker S; Department of Medical Oncology, Diskapi Yildirim Beyazid Education and Research Hospital, Ankara, Turkey.
  • Altinbas M; Department of Medical Oncology, Diskapi Yildirim Beyazid Education and Research Hospital, Ankara, Turkey.
  • Karaoglan M; Faculty of Medicine, Department of Internal Medicine, Ankara University, Ankara, Turkey.
  • Senler FÇ; Faculty of Medicine, Department of Medical Oncology, Ankara University, Ankara, Turkey.
J Gastrointest Cancer ; 53(2): 282-288, 2022 Jun.
Article em En | MEDLINE | ID: mdl-33538958
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article